子类别 期刊論文 [33/33] 會議論文/會議摘要 [8/8] 邻近社群 于重元 [19/19] 劉柯俊 [87/107] 劉滄梧 [120/126] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [85/97] 常慧如 [40/45] 張俊彥 [234/254] 張光裕 [70/80] 張憶壽 [104/107] 張文祥 [52/54] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/47] 李家惠 [29/29] 李岳倫 [49/55] 林素芳 [32/32] 楊奕馨 [44/45] 江士昇 [90/92] 沈哲宏 [14/16] 洪文俊 [88/92] 莊雙恩 [82/91] 蔡坤志 [32/35] 蔡慧珍 [67/85] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [46/49] 陳振陽 [72/72] 陳立宗 [447/518] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [39/40] 黃智興 [56/57] 黃道揚 [27/27] 丁兆治(2000-2004) [5/5] 其他 [470/478] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/56] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 社群统计 近3年内发表的文件:19(46.34%) 含全文笔数:41(100.00%) 文件下载次数统计 下载大于0次:41(100.00%) 下载大于100次:33(80.49%) 全文下载总次数:7455(0.13%) 最后更新时间: 2025-02-26 15:40 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 Intercellular TIMP-1-CD63 signaling... Pathological response following neo... Clinical outcomes and histologic fi... Cytoplasmic lipid droplets predict ... A phase 1 study of biweekly nab-pac... Outcomes of post-immunotherapy dura... Impact of previous S-1 treatment on... Neuron-derived neurotensin promotes... Germline mutations of homologous re... Systemic treatments in pancreatic c...

跳至: (选择年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目1-10 / 41. (共5页) 1 2 3 4 5 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2025-01-18	Intercellular TIMP-1-CD63 signaling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells	Molecular Cancer. 2025 Jan 18;24:Article number 25.
2024-12	Clinical outcomes and histologic findings of patients with hepatocellular carcinoma with durable partial response or durable stable disease after receiving atezolizumab plus bevacizumab	Journal of Clinical Oncology. 2024 Dec;42(34):4060-4070.
2024-11	Cytoplasmic lipid droplets predict worse prognosis in diffuse large B-cell lymphoma: Next-generation sequencing deciphering lipogenic genes	American Journal of Surgical Pathology. 2024 Nov 1;48(11):1425-1438.
2024-11	Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: A cross-trial, patient-level analysis	Lancet. Oncology. 2024 Nov;25(11):1465-1475.
2024-10	A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study	Oncologist. 2024 Oct 3;29(10):e1396-e1405.
2024-06	Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation	Biomedical Journal. 2024 Jun;47(3):Article number 100696.
2024-05	Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer	Pancreatology. 2024 May;24(3):600-607.
2024-02-15	Neuron-derived neurotensin promotes pancreatic cancer invasiveness and gemcitabine resistance via the NTSR1/Akt pathway	American Journal of Cancer Research. 2024 Feb 15;14(2):448-466.
2024-02-13	Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: A multicenter study in Taiwan	Journal of Biomedical Science. 2024 Feb 13;31:Article number 21.
2024-02-01	Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma- with emphasis on locoregional therapy for oligoprogression	Liver Cancer. 2024 Feb 01;Article in Press.

显示项目1-10 / 41. (共5页) 1 2 3 4 5 > >> 每页显示[10|25|50]项目